Prognostic and Biologic Significance of ERBB2-Low Expression in Early-Stage Breast Cancer.
JAMA Oncol. 2022 Jun 23:e222286. doi: 10.1001/jamaoncol.2022.2286. Online ahead of print.
JAMA Oncol. 2022.
PMID: 35737367